Nonstimulant medications for the treatment of ADHD.
Rains
Adrienne
A
Yale University, USA.
Scahill
Lawrence
L
Hamrin
Vanya
V
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D003891:Desipramine / Q000627:therapeutic use; D006801:Humans; D011437:Propylamines / Q000627:therapeutic use; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000929:Antidepressive Agents, Tricyclic; D000069445:Atomoxetine Hydrochloride; D003000:Clonidine; D003891:Desipramine; D011437:Propylamines; D018341:Receptors, Adrenergic, alpha-2; D017367:Selective Serotonin Reuptake Inhibitors